These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 7115524)

  • 1. [Changes in the granulocytopoietic system in erysipelatous inflammation].
    Rychnev VE; Frolov VM
    Vrach Delo; 1982 Jun; (6):104-7. PubMed ID: 7115524
    [No Abstract]   [Full Text] [Related]  

  • 2. [The use of the kallikrein-kininogen system indices in the prognosis of the development of hemorrhagic erysipelas].
    Ambalov IuM; Levina LD; Aĭtkuluev NS; Kovalenko AP; Usatkin AV
    Lab Delo; 1991; (8):44-7. PubMed ID: 1724508
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Leukocyte intracellular metabolism and phagocytic activity in patients with an erysipelatous inflammation].
    Nagoev BS; Kanukoeva MIu
    Ter Arkh; 1990; 62(11):50-3. PubMed ID: 2094990
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The peripheral hemodynamics in the inter-relapse period in erysipelatous inflammation of the lower extremities].
    Zhidkikh VN; Golodenko IA
    Vrach Delo; 1991 Jul; (7):95-7. PubMed ID: 1771850
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Clinic-laboratory characteristics of recurrence erysipelas].
    Rychnev VE; Frolov VM; Shlykova SI; Peresadin NA; Zeĭtlenok DIu
    Sov Med; 1982; (3):102-4. PubMed ID: 6179165
    [No Abstract]   [Full Text] [Related]  

  • 6. [Liver function in recurrent erysipelas].
    Frolov VM; Peresadin NA; Baskakov IN; Razenkova AT; Gurina AA
    Sov Med; 1987; (11):113-5. PubMed ID: 3445148
    [No Abstract]   [Full Text] [Related]  

  • 7. [The hemodynamic disorders in erysipelas of the lower extremities].
    Bondarov LS; Zhidkikh VN
    Ter Arkh; 1993; 65(11):55-7. PubMed ID: 8108800
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Pyrogenal in the combined therapy of erysipelatous inflammation].
    Frolov VM; Shlykova SI
    Sov Med; 1984; (1):95-8. PubMed ID: 6701664
    [No Abstract]   [Full Text] [Related]  

  • 9. [The functional characteristics of the peripheral blood granulocytes in erysipelatous inflammation].
    Krifuks OI; Tsoĭ IG; Sagimbaeva GE
    Zh Mikrobiol Epidemiol Immunobiol; 1990 Jun; (6):67-71. PubMed ID: 2220222
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Immune preparations in the overall therapy and prevention of erysipelatous inflammation].
    Khlestkov AA; Raskovalov MG; Ebert LIa
    Voen Med Zh; 1976 Jan; (1):48-9. PubMed ID: 1258419
    [No Abstract]   [Full Text] [Related]  

  • 11. Hemopoietic function of the microenvironment in chronic airway inflammation.
    Jordana M; Vancheri C; Ohtoshi T; Harnish D; Gauldie J; Dolovich J; Denburg J
    Agents Actions Suppl; 1989; 28():85-95. PubMed ID: 2683642
    [No Abstract]   [Full Text] [Related]  

  • 12. [Characteristics of the clinical course of erysipelas in the middle-aged and elderly].
    Postovit VA; Mel'k MV
    Sov Med; 1981; (3):100-4. PubMed ID: 7244822
    [No Abstract]   [Full Text] [Related]  

  • 13. [Malonaldehyde and tumor necrosis factor-alpha as indicators of intoxication syndrome in erysipelatous inflammation].
    Marzhokhova MIu; Afashagova MM; Marzhokhova AR
    Klin Lab Diagn; 2011 May; (5):20-2. PubMed ID: 21789799
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Development of elephantiasis in recurrent erysipelatous inflammation].
    Svirid AA; Shupen'ko NM; Svirid GM
    Vrach Delo; 1984 Aug; (8):87-8. PubMed ID: 6506622
    [No Abstract]   [Full Text] [Related]  

  • 15. [Characteristics of the course of erysipelatous inflammation in servicemen].
    Vitenchuk SZ
    Voen Med Zh; 1980 Mar; (3):65-7. PubMed ID: 7368612
    [No Abstract]   [Full Text] [Related]  

  • 16. [Fever therapy of chronic recurring erysipelas].
    Ehring F
    Z Hautkr; 1976 Dec; 51(23):999-1002. PubMed ID: 1007364
    [No Abstract]   [Full Text] [Related]  

  • 17. [The application wound sorption in complex treatment of destructive forms of erysipelas inflammation].
    Rybachkov VV; Potapov PP; Sal'nikov EV; Kabanov EN
    Vestn Khir Im I I Grek; 2003; 162(5):82-4. PubMed ID: 14768113
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Diagnostic and prognostic significance of some parameters of nonspecific defense humoral mechanism in patients with lymphedema complicated by erysipelas inflammation].
    Elagina LV; Savchenko TV; Pavlova MV
    Klin Med (Mosk); 1998; 76(1):25-7. PubMed ID: 9532910
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Long-term preventive use of sulfamerazine in chronic recurrent erysipelas].
    Härtel S; Gramatté T; Scholz A; Terhaag B
    Dermatol Monatsschr; 1988; 174(8):485-92. PubMed ID: 3139469
    [No Abstract]   [Full Text] [Related]  

  • 20. Phagocytosis and oxidative burst of granulocytes in the upper respiratory tract in chronic and acute inflammation.
    Müns G; Rubinstein I; Singer P
    J Otolaryngol; 1995 Apr; 24(2):105-10. PubMed ID: 7602670
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.